Jean-Luc Teillaud

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Multiple Myeloma

Systemic Lupus Erythematosus

Top Venues

Nature reviews. Cancer

Medecine sciences : M/S

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Marie-Caroline Dieu-Nosjean, Jean-Luc Teillaud
[The Nobel Prize in Physiology or Medicine 2023: Katalin Karikó and Drew Weissman - A vaccine revolution driven by fundamental research in immunology and molecular biology]. Medecine sciences : M/S 40 (2) (2024)
Jean-Luc Teillaud, Ana Houel, Marylou Panouillot, Clémence Riffard, Marie-Caroline Dieu-Nosjean
Tertiary lymphoid structures in anticancer immunity. Nature reviews. Cancer (2024)
Jean-Luc Teillaud, Ana Houel, Marylou Panouillot, Clémence Riffard, Marie-Caroline Dieu-Nosjean
Tertiary lymphoid structures in anticancer immunity. Nature reviews. Cancer 24 (9) (2024)
Jean-Luc Teillaud, Ana Houel, Marylou Panouillot, Clémence Riffard, Marie-Caroline Dieu-Nosjean
Tertiary lymphoid structures in anticancer immunity. Nature reviews. Cancer 24 (9) (2024)
Marie-Caroline Dieu-Nosjean, Jean-Luc Teillaud
[The Nobel Prize in Physiology or Medicine 2023: Katalin Karikó and Drew Weissman - A vaccine revolution driven by fundamental research in immunology and molecular biology]. Medecine sciences : M/S 40 (2) (2024)
Sahar Kassem, Béré K Diallo, Nizar El-Murr, Nadège Carrié, Alexandre Tang, Alain Fournier, Hélène Bonnevaux, Céline Nicolazzi, Marine Cuisinier, Isabelle Arnould, Sukhvinder S Sidhu, Jill Corre, Herve Avet-Loiseau, Jean-Luc Teillaud, Helgi van de Velde, Dmitri Wiederschain, Marielle Chiron, Ludovic Martinet, Angela Virone-Oddos
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma. Blood 139 (8) (2022)
Benoît Gamain, Carine Brousse, Nathan Earl Rainey, Béré K Diallo, Clara-Eva Paquereau, Alexandra Desrames, Jolita Ceputyte, Jean-Philippe Semblat, Olivier Bertrand, Stéphane Gangnard, Jean-Luc Teillaud, Arnaud Chene
BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells. Science advances 8 (6) (2022)
Ana Victoria Casadesús, Claire Deligne, Béré Kadjdiatou Diallo, Katya Sosa, Nathalie Josseaume, Circe Mesa, Kalet León, Tays Hernández, Jean-Luc Teillaud
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy. Oncoimmunology 9 (1) (2020)